Tourmaline Bio Inc (TRML) Return on Investment ROI from the second quarter of 2025 to second quarter of 2024 and for the year 2025, average high and low, overall ranking from Jun 30 2025 to Jun 30 2024 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Tourmaline Bio Inc   (NASDAQ: TRML)


Tourmaline Bio Inc's ROI from its second quarter of 2025 to the second quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Tourmaline Bio Inc's ROI in the second quarter of 2025?
Tourmaline Bio Inc recorded a cumulative net loss of $-88 million during 12 months ending in the second quarter of 2025, resulting in a negative return on investment (ROI) of -30.5%.

Within the Healthcare sector 414 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2025 from 3274 to 3599.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter
Y / Y Investment Change TTM 36.39 % 163.55 % 1362.47 % - 661.47 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 259 280 300 321 338
Return On Investment (TTM) -30.5 % -26.74 % -22.29 % -16.03 % -16.11 %
TRML's Overall Ranking # 3599 # 3274 # 2664 # 3090 # 2619
Seq. Investment Change TTM -6.39 % -5.67 % 7.78 % 43.31 % 80.88 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -88 -83 -73 -49 -34

TRML Company Profile >> Back to TRML Roi Comparisons >> See Annual TRML Return On Investment



Return On Investment TRML's Ranking
Within: No.
Industry # 48
Sector # 415
Overall # 3599

Return On Investment Statistics
High Average Low
-13.71 %
-27.43 %
-43.28 %
(Jun 30 2024)   (Jun 30 2023)







Financial Statements
Tourmaline Bio Inc's II. Quarter Investments $ 259 Millions TRML's Balance sheet
Tourmaline Bio Inc's II. Quarter Income $ -23 Millions Quarterly TRML's Income Statement
TRML's Income by Division See TRML's Income by Division


TRML Annual Return On Investment (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 300 205 182 243 0
Y / Y Investment Growth 46.18 % 12.64 % -25.13 % - -
Net Income in Millions -73 -42 -74 -48 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -24.4 % -20.52 % -40.54 % -19.65 % -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
TRML's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for TRML's Competitors
Subscribers only: Roi for Tourmaline Bio Inc's Suppliers
Subscribers only: Return On Investment for TRML's Customers

Other Ratios
TRML's Roa TRML's Inventory Turnover Ratio TRML's Growth Rates TRML's Dividend Statistics
TRML's Profitability Ratios TRML's Asset Turnover Ratio TRML's Dividend Growth
TRML's Roe TRML's Valuation Ratios TRML's Financial Strength Ratios TRML's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2025, within Healthcare Sector ROI

Date modified: 2026-09-08T22:38:36+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.